We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERICS STILL BATTLING BRAND TACTICS ONE YEAR AFTER PATENT REFORMS
GENERICS STILL BATTLING BRAND TACTICS ONE YEAR AFTER PATENT REFORMS
August 10, 2004
One year after the FDA implemented sweeping new patent rules to better balance the competition between brand and generic drugmakers, generic firms say brand firms are threatening the industry with a new tactic: cutting deals with generic firms to market authorized generic products.